Compounded oral versions may use different formulation strategies, and the delivery mechanism and bioavailability profile may differ from FDA-approved branded versions
Stratified by GLP-1 related and non GLP-1 related treatments In the included RCTs, GLP-1 related drugs (including liraglutide, semaglutide, beinaglutide, exenatide, and AMG133) showed significant weight regain compared with control group (WMD = 1.78 kg, 95% CI 0.76 to 2.80, P = 0.006, I 2 = 85%)
Key Takeaways Semaglutide, Tirzepatide, and Retatrutide are GLP-1 (glucagon-like peptide-1) medications, each offering increasing efficacy through multi-receptor targeting
While early oral versions were less effective, largely due to poor absorption from the gut, we now have new oral formulations with improved absorption and adjusted dosing so you can see greater results without needing injections
If your platform provides a semaglutide dosage calculator , use it